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ABSTRACT An early step in activation of leukocyte adhesion is a release of integrins from cytoskeletal constraints on their
diffusion, leading to rearrangement and, consequently, increased avidity. Static adhesion assays using puriﬁed ligand as
a substrate have demonstrated that very low doses of cytochalasin D disconnect b2-integrins from their cytoskeletal links,
allowing rearrangement and activating adhesion. The adhesion process in blood vessels is poorly simulated by these assays,
however, for two reasons: leukocyte adhesion to endothelium 1), occurs in the presence of blood ﬂow and 2), involves the
simultaneous interactions of multiple sets of adhesion molecules. We investigated the effect of cytochalasin D, at concen-
trations that increase integrin diffusion but do not alter leukocyte shape and surface features, on adhesion of leukocytes to
endothelial cells under ﬂow. Cytochalasin D increased the number of rolling cells, the number of ﬁrmly adherent cells, and the
duration of both rolling and ﬁrm adhesion. These effects required endothelial cell expression of ICAM-1, the ligand for leukocyte
b2-integrins. The b2-integrin–ICAM-1 interaction alone was not sufﬁcient, however. Experiments using puriﬁed substrates
demonstrated that avidity effects on activation of adhesion under ﬂow require functional cooperativity between integrins and
other adhesion receptors.
INTRODUCTION
The physiology of inﬂammatory reactions depends on the
recruitment of leukocytes into tissues, which depends on
regulated adhesion of leukocytes to the blood vessel wall. A
key point in the regulation of adhesion is control of
leukocyte integrin function. Adhesion via integrins is
regulated by two mechanisms: 1), changes in the ligand-
binding afﬁnity of the individual integrin molecule and 2),
rearrangement of the integrins, which increases the avidity of
the interaction. Recent advances in understanding confor-
mational changes associated with integrin activation have
helped to elucidate the role of afﬁnity modulation (Lu et al.,
2001a,b; Shimaoka et al., 2002, 2003; Takagi et al., 2001;
Hantgan et al., 1999, 2001; Vinogradova et al., 2000, 2002;
Salas et al., 2002). The role of integrin rearrangement,
however, remains less well understood.
Rearrangement of integrins on leukocytes upon cell
activation occurs not by directed movement, but rather by
diffusion, which occurs after release of cytoskeletal con-
straints on integrin motion (Kucik et al., 1996; Yauch et al.,
1997; Sigal et al., 2000). Integrin rearrangement increases
avidity both by allowing receptors to move to areas of high
ligand density (Kucik et al., 1996), and also by receptor
clustering (Lub et al., 1997). Theory predicts that clustering
alone can lead to increased avidity, due to cooperative effects
on resistance to bond breakage (Ward et al., 1994). Direct
evidence that the cooperative binding associated with
clustering increases adhesion has been provided by atomic
force microscopy (Chen and Moy, 2000).
So far, the only adhesion molecules shown to adjust their
avidity on a rapid timescale by rearrangement are the b2-
integrins, which are specialized for leukocyte adhesion. Both
aLb2 (Lub et al., 1997) and aMb2 (Zhou and Li, 2000; Zhou
et al., 2001; Jones et al., 1998) increase avidity by diffusion
and rearrangement. The principal ligand for both of these
leukocyte integrins is intercellular adhesion molecule 1
(ICAM-1) (Diamond et al., 1990; Lub et al., 1996).
Physiologically, activation of integrin-mediated adhesion
occurs in the context of activation of the whole leukocyte.
Leukocyte activation affects many functions, including
adhesion, production of cytokines, and proliferation. To
understand the effects of integrin rearrangement, therefore,
control of integrin diffusion must be separated experimen-
tally from other effects of cell activation. The phorbol ester
PMA (phorbol 12-myristate 13-acetate) is often used to
activate integrin adhesion experimentally, but PMA has
myriad effects, including changes in surface morphology and
induction of cell spreading. To isolate the effects of integrin
rearrangement from other effects of cell activation, cyto-
chalasin D, at a concentration that has minimal effects on
cytoskeletal architecture, has proven to be a useful tool. We
showed previously that a low dose of cytochalasin D (0.3–1
mg/ml), too small to grossly disrupt the structure of the actin
cytoskeleton, is able to release integrins from cytoskeletal
constraints on their motion, as measured directly by single
particle tracking (SPT) (Kucik et al., 1996). This treatment
caused integrin rearrangement and activated lymphocyte
adhesion. Several studies from a number of laboratories have
demonstrated that low-dose cytochalasin D increases
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diffusion of b2-integrins on a variety of leukocyte types (van
Kooyk and Figdor, 1997; Yauch et al., 1997; Stewart et al.,
1998; van Kooyk et al., 1999), including the WEHI 274.1
cell line (Zhou and Li, 2000), with little effect on other cell
functions. The utility of low-dose cytochalasin D in in-
creasing integrin avidity has since been conﬁrmed in a
number of systems (Lub et al., 1997; Stewart et al., 1998;
Yauch et al., 1997; Zhou and Li, 2000; van Kooyk et al.,
1999). Although cytochalasin D effects on integrin diffusion
and clustering are well documented, there is no evidence that
cytochalasin D has any effect on integrin conformation
(Kucik, 2002).
The biphasic effect of cytochalasin D on adhesion
(activation at low concentrations, inhibition at higher
concentrations) has been explained as follows (Kucik et al.,
1996). At low doses, cytochalasin D activates b2-integrin–
mediated adhesion through its effects on integrin diffusion.
These low doses sever the link between b2-integrins and
actin ﬁlaments, without major disruption of the cytoskeleton,
while high doses prevent reinforcement of nascent contacts.
(Kucik et al., 1996). Because no speciﬁc integrin-mobilizing
drugs have yet been identiﬁed, cytochalasin D is still the best
tool available to increase integrin diffusion.
Although it is well established that rearrangement of
integrins activates adhesion to puriﬁed ICAM-1 under static
conditions, its role in leukocyte adhesion to endothelial cells
in the presence of shear is less clear. Shear changes the
biophysics of adhesion, requiring rapid formation of adhe-
sive bonds to resist the forces that would pull a leukocyte
free of the endothelium. Static assays of adhesion, therefore,
poorly simulate the adhesion that occurs in blood or lymph
vessels. The relative importance of afﬁnity changes and
integrin rearrangement in the presence of shear stress has not
been worked out.
Similarly, although much is known about the role of
integrin rearrangement in activating adhesion to puriﬁed
ICAM-1, less is known regarding diffusion-mediated re-
ceptor rearrangement in the context of simultaneous binding
of multiple sets of adhesion receptors. When leukocytes bind
to vascular endothelium, a number of adhesion receptors and
their ligands are available for binding. The importance of
cooperativity among endothelial selectins, b2-integrins, and
other adhesion receptors is increasingly becoming appreci-
ated (Steeber et al., 1998, 1999; Henderson et al., 2001).
To address the role of integrin rearrangement in adhesion
under ﬂow and the contribution of cooperative binding
among different classes of adhesion molecules, we used
a laminar ﬂow adhesion assay system. We measured the
effect of cytochalasin Dmobilization of integrins on adhesion
of a leukocyte cell line to both cultured endothelium and
puriﬁed ligand substrates. We chose the WEHI 274.1 cell
line, a well-established monocyte-like cell line used to study
monocyte adhesion (Warner et al., 1979; Yue et al., 2000;
Zhou and Li, 2000). In previous work, we demonstrated that
the adhesive properties of this cell line on TNF-a stimulated
endothelium were similar to those of whole blood monocytes
(Kevil et al., 2001). In addition, it has been established that
low doses of cytochalasin D increase b2-integrin diffusion on
the WEHI 274.1 cell line (Zhou and Li, 2000) and that this
increased diffusion activates adhesion in static assays (Zhou
and Li, 2000; Zhou et al., 2001). In this study, we found that
receptor rearrangement has consequences for both monocyte
rolling and ﬁrm adhesion, and that these effects are enhanced
by cooperative interactions among classes of adhesion
molecules. This conﬁrms that receptor rearrangement by
diffusion can play an important role in adhesion of leukocytes
to vascular endothelium under ﬂow. In addition, these
ﬁndings suggest that cooperativity between the ICAM-1–
integrin receptor-ligand pair and other sets of adhesion
molecules may be more important in the adhesion process
than previously supposed.
MATERIALS AND METHODS
Cells and treatments
Endothelial cells puriﬁed from mouse aorta were isolated as previously
described (Kevil and Bullard, 2001) and cultured in dishes precoated with
1% gelatin (Sigma, St. Louis, MO). The cells were maintained for seven
days in MCDB 131 media (Gibco, Grand Island, NY) supplemented with
10% FBS (HyClone, Logan, UT), 10 mg/L bovine brain extract (Biomedical
Technologies, Stoughton, MA), 1000 units/L heparin (American Pharma-
ceutical Partners, Los Angeles, CA), 1 mg/L hydrocortisone (Sigma, St.
Louis, MO), and 10 ml penicillin (Gibco). The cells were seeded in 8-cm2
tissue culture plastic dishes (Corning, Corning, NY) coated with 1% gelatin
(Sigma). The cells formed conﬂuent monolayers 6–7 days after seeding and
were used for experiments within 2–3 days.
WEHI 274.1 cells were obtained from ATCC and were cultured in
DMEM (Gibco) containing 10% FBS and 4 ml 2-mercaptoethanol (Sigma).
In vitro rolling and adhesion assay
Cells of the WEHI 274.1 monocyte-like cell line were loaded with
ﬂuorescent dye by 20 min incubation at room temperature with 1 mM
BCECF (29, 79 -bis-carboxyethyl-5-carboxyﬂuorescein; Molecular Probes,
Eugene, OR) and suspended in Hanks’ balanced salt solution (HBSS)
(Sigma) at a concentration of 0.53 106/ml. The cells were then treated with
cytochalasin D (Sigma) at 0, 0.3, 1.0, or 3.0 mg/ml for 30 min at 378C,
washed once in HBSS, resuspended in HBSS at 106 cells/ml, and loaded into
a 25-ml syringe.
Eight hours before the ﬂow chamber experiment, a conﬂuent monolayer
of endothelial cells in tissue culture dishes were treated with 10 ng/ml of
murine TNF-a (Sigma) to activate the endothelium. For ﬂow experiments,
a GlycoTech (Rockville, MD) ﬂow chamber insert and gasket were inserted
into the dish to form a laminar ﬂow chamber that can be viewed on
a microscope. Cells were injected into the ﬂow chamber in HBSS at
a controlled physiological shear stress of 2.5 dynes/cm2 using a pro-
grammable syringe pump (KD Scientiﬁc, New Hope, PA). Cells were
viewed on an Axiovert 100 microscope (Zeiss, Thornwood, NY) equipped
with a CCD camera (Model 300T-RC, Dage-MTI, Michigan City, IN) and
viewed both as brightﬁeld and ﬂuorescent images. Video was recorded onto
sVHS videotape, and selected sequences were digitized to TIF ﬁles using the
Perception video editing package (Perception PVR-2500, Digital Processing
Systems, Markham, Ontario, Canada). Video images were analyzed to yield
position measurements every 1/30 s using Metamorph software (Universal
Imaging Corporation, West Chester, PA). Position measurements were
processed by programs written for this purpose by Dennis Kucik to
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determine velocities, accelerations, and arrest durations. Counts of rolling
and ﬁrmly adherent cells were determined by visual review of video
sequences and conﬁrmed by computer analysis.
Analysis of leukocyte adhesion
Deﬁnition of adhesion duration
Even ﬁrmly adherent cells move slightly under shear stress. Therefore, an
objective deﬁnition of adhesion must be used, especially when cells are
observed at high time resolution. A cell was considered ﬁrmly adhered if its
velocity fell below 5 m/s for ﬁve video frames (0.16 s). This is equivalent to
movement of one cell diameter in 3 s. (Note that average adhesion durations
were much longer, averaging 5–25 s, as seen in Fig. 5 a). Duration of
adhesion was deﬁned as the time until the cell resumed motion at a velocity
greater than 5 m/s for more than ﬁve frames. In general, the transition from
arrest to rolling was not subtle, but rather was an abrupt resumption of
rolling motion.
Deﬁnition of rolling
To distinguish cells that are rolling from those ﬂowing at the lowest
hydrodynamic velocity (close to the chamber wall) without adhesive rolling
interactions, a critical velocity (Vcrit) was calculated as described earlier
(Kevil et al., 2003). Rolling was then deﬁned as cell motion that does not
meet the criteria for adhesion (above) but is below Vcrit. Average rolling
velocity is the mean of the instantaneous velocities (measured at 1/30-s
intervals) during the period that the cell is rolling. Rolling duration is the
total time that the cell is rolling (number of frames3 0.033 s/frame). If a cell
rolled intermittently (i.e., rolling was interrupted by either free ﬂow or ﬁrm
adhesion), only the frames during which the cell met the criteria for rolling
were averaged.
Cell deformability index measurements
Images of rolling cells were observed and recorded onto videotape, and
selected sequences were digitized at 30 frames/s into TIF images at
a resolution of 720 3 486 pixels using DPS Reality hardware and software
(Leitch Technology Corporation, Florence, KY). The TIF sequences were
played as movies and reviewed to identify rolling and adherent cells, and
individual TIF images were selected for analysis. Using these original,
sharp, still pictures, length and width of cells interacting with the
endothelium were measured using Metamorph software (Universal Imaging
Corporation) to an accuracy of 60.44 m, based on the magniﬁcation of the
system and assuming single-pixel resolution. Ratios were then calculated to
yield cell deformability indices (Finger et al., 1996). Between 10 and 50 cells
were measured for each cytochalasin D concentration.
Scanning electron microscopy
Thermanox coverslips (Electron Microscopy Sciences, Fort Washington,
PA) were incubated with 500 ml poly-L-lysine (PLL, Sigma) for 30 min at
378C, the PLL was removed, and the coverslips were washed 5 times with
SEM buffer (0.1 M cacodylate buffer in water, pH 7.2, Electron Microscopy
Sciences). For each coverslip, 0.2 3 106 WEHIs were washed once with
HBSS and incubated for 45 min at 378C. Cells were then ﬁxed with 2.5%
electron microscopy grade glutaraldehyde (Electron Microscopy Sciences)
in SEM buffer for 20 min at room temperature. They were then washed with
SEM buffer 3 times, immersed in 1% osmium tetroxide in SEM buffer for
1 h at room temperature, and then washed with SEM buffer three times.
Coverslips were rinsed with distilled H2O and dehydrated at room
temperature with 50%, 75%, and 95% EtOH for 4 min each, and then
3 times with 100% EtOH for 4 min each time. Cells were then dehydrated
at room temperature with 1:1 100% EtOH and hexamethyldisilizane
(HMDS, Electron Microscopy Sciences) for 4 min, then twice with 100%
HMDS for 4 min, and allowed to air dry overnight with a shallow covering
of HMDS. Coverslips were then coated with gold and attached to an SEM
stub with tape or rubber cement before SEM scanning.
Puriﬁed substrate coating
Tissue culture dishes (35 mm) were marked with a diamond pen to outline
a small area in the center. Then 10ml of 20mg/ml protein A (Sigma) in PBS
was placed in the marked area and spread with the pipette tip, incubated at
378C for 1 h, and then washed three times with PBS. Nonspeciﬁc binding
was blocked with 2% human serum albumin (HSA, Sigma) in PBS for 2 h at
48C followed by 3 washes with PBS. The marked areas were then coated
with 50 ml puriﬁed substrate (25 mg/ml recombinant mouse ICAM-1/Fc
chimera, 5 mg/ml recombinant mouse VCAM-1/Fc chimera, 0.5 mg/ml
recombinant mouse E-selectin/Fc chimera, 0.5 mg/ml recombinant mouse
P-selectin/Fc chimera, 16.8 mg/ml ICAM-1/10 mg/ml E-selectin double-
coated, or 25 mg/ml ICAM-1/0.5 mg/ml E-selectin double-coated) overnight
in 48C. All puriﬁed coatings were obtained from R&D Systems,
Minneapolis, MN.
One-minute adhesion assay
WEHI 274.1 cells were suspended in HBSS at a concentration of 1.25 3
106/ml. The cells were then treated with cytochalasin D at 0, 0.3, 1, and
3 mg/ml or 100 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma) for 30
min at 378C and washed once with HBSS. The cells were allowed to
settle on the substrate-coated dishes for 1 min without ﬂow, and then sub-
jected to increasing shear stresses, incrementing every 7 seconds. Flow
rates and durations were controlled by a PC using software written in the
laboratory to operate a programmable syringe pump (KD Scientiﬁc). At the
end of each interval the number of cells that remained bound was determined
relative to the number of cells that had originally settled under static condi-
tions. For each shear rate, adhesion was quantiﬁed in several ﬁelds of view.
RESULTS
Cytochalasin D activates adhesion of WEHI
monocytes to cultured endothelium
under shear ﬂow
Mouse aortic endothelial cells were cultured as an intact
monolayer in a laminar ﬂow chamber and stimulated with
TNF-a (10 ng/ml 3 8 h). WEHI 274.1 cells were then
perfused at a physiologic shear stress of 2.5 dynes/cm2 and
the number of adherent cells per minute was determined
(Fig. 1 a). A low concentration of cytochalasin D activated
adhesion in a dose-dependent manner, whereas at higher
concentrations adhesion was low, similar to untreated con-
trols. Peak adhesion occurred at 0.3 mg/ml, where adhesion
was increased greater than ﬁvefold. This dose dependence is
consistent with earlier studies measuring adhesion of lym-
phocytes to puriﬁed ICAM-1 under static conditions (Kucik
et al., 1996).
Cytochalasin D activation of adhesion is
ICAM-1–dependent
To conﬁrm the role of b2-integrins, similar experiments were
done using cultured aortic endothelium from ICAM-1 /
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mice (Fig. 1 b). On endothelium lacking ICAM-1, cyto-
chalasin D was unable to induce the large increases in
adhesion seen on wild-type endothelial cells. Although there
was no effect at all at 0.3 mg/ml cytochalasin D, a small but
signiﬁcant increase in adhesion was seen at 1 mg/ml. This
suggests that although ICAM-1 is important for cytochalasin
D-induced activation of adhesion, other adhesion molecules
may be involved as well.
Cytochalasin D activates rolling adhesion
in an ICAM-1-dependent manner
Binding of b2-integrins to ICAM-1 has been shown to
cooperate with selectins in stabilization of leukocyte rolling
(Steeber et al., 1998, 1999; Kevil et al., 2003; Henderson
et al., 2001). Therefore, we tested whether cytochalasin D
could activate WEHI 274.1 rolling on cultured endothelium
from both wild-type and ICAM-1 / mice. Treatment of
the WEHI cells with cytochalasin D dramatically increased
the number of rolling cells in a dose-dependent manner, but
only on endothelium that expressed ICAM-1 (Fig. 2).
The concentrations of cytochalasin D that
activate adhesion do not change WEHI
surface morphology
To test the effect of adhesion molecule rearrangement under
ﬂow, it is important to be certain that cell morphology is not
altered, since this would affect the forces exerted on the cell
and confound interpretation of results. In addition, loss of
microvilli and other surface features could affect cell contact
area. Therefore, we examined the effect of cytochalasin D on
WEHI cell morphology. We found that at a concentration
known to largely disrupt the cytoskeleton and inhibit ad-
hesion in static assays (3 mg/ml), the surface of the cell
became smoother and microvilli were lost (Fig. 3 d). At the
lower doses that activate adhesion, however, cell morphol-
ogy was largely unaffected (Fig. 3, b and c). Thus, effects on
cell adhesion are more likely due to mobilization of
cytoskeleton-restricted receptors than to cell shape changes.
Cytochalasin D does not increase deformation
of WEHI 274.1 cells at a shear stress
of 2.5 dynes/cm2
Cells under shear tend to become slightly elongated in the
direction of ﬂow. In neutrophils, low doses of cytochalasin
D can have signiﬁcant effects on cortical tension and
cytoplasmic viscosity (Wakatsuki et al., 2001; Finger et al.,
1996; Ting-Beall et al., 1995), which might affect cell
deformability. This effect can be quantiﬁed by calculating
FIGURE 1 Cytochalasin D activates adhesion under ﬂow in a dose-
dependent manner. Nonrolling adhesion (arrest) of WEHI 274.1 cells on
cultured primary endothelial cells from both wild-type (a) and ICAM-1/
(b) mouse aortas was quantiﬁed. At a physiologic shear stress of 2.5 dynes/
cm2, adhesion was increased ﬁvefold on wild-type endothelium by low-dose
cytochalasin D. On ICAM-1 / endothelium, the probability of arrest was
lower. Cytochalasin D had no effect on adhesion at 0.3mg/ml, although
a small increase was seen at 1.0 mg/ml.
FIGURE 2 Cytochalasin D activation of rolling requires ICAM-1. Rolling
adhesion on both wild-type (squares) and ICAM-1 / (triangles)
endothelium at a shear stress of 2.5 dynes/cm2 was quantiﬁed. Cells were
more likely to roll on endothelium that expressed ICAM-1. Moreover, on
wild-type endothelium only, rolling was increased up to fourfold by low-
dose cytochalasin D, with a dose dependence similar to that for ﬁrm
adhesion.
FIGURE 3 Effect of cytochalasin D on WEHI monocyte morphology.
The low doses of cytochalasin D that activate adhesion (b and c) do not
cause gross morphological changes, as compared to control (a). Higher
doses that inhibit adhesion, however, cause loss of cell surface features (d).
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a deformation index, which is the ratio of cell length to cell
width (Finger et al., 1996). To quantify deformability of
WEHI 274.1 cells under our ﬂow conditions, we calculated
deformability indices for rolling cells as a function of cyto-
chalasin D concentration. Lengths and widths of cells were
measured with an accuracy of 6 0.44 m. We found no sig-
niﬁcant increase in deformability at the cytochalasin D
concentrations and shear stress used in this study (Fig. 4).
Cytochalasin D increases duration of both
rolling and ﬁrm adhesion
To better understand the role of integrin rearrangement in
cell adhesion under ﬂow, we quantiﬁed duration of adhesion
and rolling as a function of cytochalasin D treatment. We
found that cytochalasin D increased the duration of both ﬁrm
adhesion (Fig. 5 a) and rolling (Fig. 5 b). Interestingly,
whereas the increase in ﬁrm adhesion duration peaked at 0.3
mg/ml, increased rolling duration was sustained even at
a concentration high enough (3 mg/ml) to disrupt cytoskel-
etal architecture (as seen by the morphological changes in
Fig. 3), indicating that an intact cytoskeleton is less im-
portant for rolling than for ﬁrm adhesion. Adhesion and
rolling durations were not determined for ICAM-1 /
endothelium due to the small number of adherent and rolling
cells.
Cytochalasin D does not affect rolling velocity
Rolling velocities for WEHI cells on wild-type endothelium
were calculated by computer 30 times per second, and an
average velocity for each cell was determined. Velocities
were then plotted as histograms (Fig. 6) to compare the
distribution of rolling velocities with and without cytocha-
lasin D. Between 48 and 220 cell velocities were measured to
produce each velocity histogram; more velocity data were
available at 0.3 and 1.0 mg/ml cytochalasin D, due to
increased rolling efﬁciency at those doses (cf. Fig. 2). We
found that, even though cytochalasin D treatment affected
the number of cells rolling on wild-type endothelium,
average velocities were not signiﬁcantly different. Similarly,
cytochalasin D had no effect on rolling velocities in ICAM-1
/ endothelium (data not shown).
Cytochalasin D does not activate adhesion
or rolling on puriﬁed VCAM-1 under
ﬂow conditions
The leukocyte integrin a4b1 mediates both rolling and
ﬁrm adhesion via binding to VCAM-1. In addition, like the
b2-integrins, adhesion via a4b1 is activatable. To determine
whether a4b1-mediated adhesion was affected by cytocha-
lasin D, we measured binding of WEHIs to puriﬁed
VCAM-1 in the ﬂow chamber. As with selectin substrates,
cytochalasin D did not activate adhesion to puriﬁed VCAM-1
under ﬂow (Fig. 7 a). When the cells were allowed to
settle for 1 min and then exposed to ﬂow (Fig. 7 b),
cytochalasin D was still unable to increase adhesion
signiﬁcantly, though adhesion could be activated by PMA.
Cytochalasin D does not activate rolling
adhesion on puriﬁed endothelial selectins
under ﬂow conditions
Adhesion of leukocytes to vascular endothelium involves
the simultaneous binding of several sets of adhesion
molecules to their ligands. To conﬁrm that the major effect
of cytochalasin D treatment was on leukocyte integrins rather
FIGURE 4 Effect of cytochalasin D on WEHI cell deformability. Cell
deformability indices (ratio of cell length to cell width under conditions of
shear stress) were calculated for rolling and adherent cells at the shear stress
used for adhesion assays (2.5 dynes/cm2) and mean 6 SD were plotted as
a function of cytochalasin D dose. No signiﬁcant increase in deformability
index was observed at the cytochalasin D concentrations used in this study.
FIGURE 5 Duration of adhesion and rolling. Duration of arrest (a) and
rolling (b) were quantiﬁed for WEHI monocytes on wild-type endothelium
at a shear stress of 2.5 dynes/cm2. Cell trajectories were divided into
segments in which the cell was rolling or stopped, as deﬁned in Materials
and Methods, to calculate these quantities. The bar graphs represent mean
duration (6 SE) of these segments for each cytochalasin D concentration.
Cytochalasin D increased duration of both types of adhesion.
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than on selectin ligands, we measured rolling and adhesion
of WEHIs to puriﬁed endothelial selectin substrates. We
found that cytochalasin D treatment had no signiﬁcant effect
on the number of WEHIs rolling on or adhering to P-selectin
(Fig. 8 a). On puriﬁed E-selectin, cytochalasin D treatment
actually decreased the likelihood of rolling (Fig. 8 b). As
expected, since the selectins are primarily rolling receptors,
there was very little ﬁrm adhesion to either substrate (data
not shown).
A mixed substrate of ICAM-1 and E-selectin
reconstituted the dose-dependent effect of
cytochalasin D on adhesion
To conﬁrm the role of ICAM-1 in cytochalasin D-activated
adhesion, we measured adhesion of WEHI cells to puriﬁed
ICAM-1. Baseline adhesion on the puriﬁed substrates
differed, and seemed to be related to the ability of each
substrate to capture cells from the ﬂowing medium (Fig. 9
a). We found, however, that under ﬂow, adhesion to
puriﬁed ICAM-1 alone or on puriﬁed E-selectin alone was
not increased by cytochalasin D treatment (Fig. 9 b). On
a mixed substrate of both ICAM-1 and E-selectin, though,
cytochalasin D was able to increase adhesion in a dose-
dependent manner. This demonstrates the need for
FIGURE 6 Cytochalasin D does not affect rolling velocity. Velocities of
WEHI monocytes rolling on wild-type endothelium were quantiﬁed, and the
distribution of average velocities was expressed as velocity histograms. The
difference in bar heights among panels reﬂects differences in efﬁciency of
cell capture, consistent with Fig. 2. Although cytochalasin D affected the
number of rolling cells, the average velocity of those that rolled was not
affected.
FIGURE 7 Cytochalasin D does not activate rolling or adhesion on
puriﬁed VCAM-1. (a) To test for an effect of cytochalasin D on a4b1-
integrin avidity, rolling and ﬁrm adhesion of WEHI monocytes were
quantiﬁed at a shear stress of 2.5 dynes/cm2 on a substrate of the a4b1 ligand
VCAM-1. Low dose cytochalasin D was unable to activate either type of
adhesion. (b) Adhesion of WEHI monocytes to puriﬁed VCAM-1 with
1 min static incubation. WEHI cells were allowed to settle on VCAM-1 for
1 min before being subjected to a shear stress of 2.5 dynes/cm2. Cytochalas-
in D was unable to increase adhesion in this static assay, whereas
PMA-induced adhesion was clearly demonstrable.
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cooperativity among adhesion receptors in activation of
adhesion under ﬂow.
DISCUSSION
In this study, we found that treatment of WEHI 274.1
monocytic cells with low concentrations of cytochalasin D
increased adhesion to vascular endothelium under ﬂow. Both
rolling and ﬁrm adhesion were increased in both frequency
and duration.
It was shown previously that cytochalasin D, at low
concentrations, increases b2-integrin diffusion in the WEHI
274.1 cell line with little effect on other cell functions (Zhou
and Li, 2000). Increased diffusion then results in increased
integrin clustering (van Kooyk and Figdor, 1997; van Kooyk
et al., 1999). The pro-adhesive effect of low doses of cyto-
chalasin D on b2-integrin–mediated adhesion is well
established for static adhesion (van Kooyk and Figdor,
1997; Yauch et al., 1997; Stewart et al., 1998; van Kooyk
et al., 1999; Zhou and Li, 2000), but had not been shown to
operate under ﬂow.
For ﬂow studies, it was important to conﬁrm that low-dose
cytochalasin D does not alter cell morphology. This is
because alterations in cell surface features can change the
proﬁle presented to the ﬂowing ﬂuid, and, thus, the forces
exerted on the leukocyte. We demonstrated by scanning
electron microscopy that the cytochalasin D concentration
that activates adhesion is lower than that needed to alter
surface morphology. Fig. 3 demonstrates that at higher
concentrations of cytochalasin D (3 mg/ml), microvilli
collapse, making the cell surface smoother. This might
increase contact area and/or decrease the forces exerted on
the cell by the ﬂuid ﬂow. Since the pro-adhesive effect of
cytochalasin D was at lower concentrations, though, where
effects on surface morphology are not obvious (Fig. 3, b and
c), it cannot be attributed to these cell shape changes. Note,
however, that this does not rule out effects on the mechanical
properties of microvilli with low-dose cytochalasin D.
It was also important, however, to examine changes in
morphology under ﬂow. If low concentrations of cytocha-
lasin D were to signiﬁcantly decrease cell stiffness, de-
formation of cells under shear stress might be increased. In
neutrophils, cytochalasin D can have signiﬁcant effects on
cortical tension and cytoplasmic viscosity, even at relatively
low doses (Ting-Beall et al., 1995; Wakatsuki et al., 2001;
Finger et al., 1996). To determine whether decreased cortical
tension affected WEHI 274.1 deformability and, thus, cell
shape in the presence of shear, we used digital image
processing to calculate deformation indices (Finger et al.,
1996) for rolling and adherent cells as a function of
cytochalasin D concentration. Using an imaging system
developed for high temporal and spatial resolution (Kevil
FIGURE 8 Cytochalasin D does not activate rolling on puriﬁed selectins.
To test whether low-dose cytochalasin D affects avidity of selectin ligands,
rolling was quantiﬁed on substrates of puriﬁed P-selectin (a) and E-selectin
(b). Cytochalasin D was unable to activate selectin-mediated rolling
adhesions and actually signiﬁcantly decreased rolling on E-selectin.
FIGURE 9 Adhesion to a mixture of puriﬁed ICAM-1 and E-selectin.
WEHI monocytes were perfused at a shear stress of 2.5 dynes/cm2 over
substrates of puriﬁed ICAM-1, E-selectin, or a mixture of both. (a) Baseline
adhesion to puriﬁed substrates without cytochalasin D treatment. Note that
interaction of ﬂowing cells with ICAM-1 alone is poor. (b) To compare
activation of adhesion by cytochalasin D, baseline values are normalized to
zero, and changes in adhesion are plotted as a function of cytochalasin D
concentration. Although cytochalasin D failed to activate adhesion on either
puriﬁed ICAM-1 or E-selectin alone, a dose-dependent effect similar to that
seen with whole endothelium was observed with both adhesion molecules
combined.
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et al., 2003), we were able to image our cells under ﬂow at
high enough resolution to reliably determine cell shape (with
an accuracy of 60.44 m). Under the relatively low shear
stress conditions used in this study (2.5 dynes/cm2), there
was no signiﬁcant effect of cytochalasin D on cell
deformability (Fig. 4). This does not rule out changes in
the mechanical properties of the cells that might be detected
by a more sensitive assay. It does clearly show, though, that
low-dose cytochalasin D did not change the mechanical
properties of the cells enough to cause them to be
signiﬁcantly more deformable under the conditions used
for our adhesion assays.
It should be noted that effects of cytochalasin D on the
physical properties of microvillous tethers between leuko-
cytes and endothelial cells cannot be ruled out by this study.
It is possible that changes in microvillus compliance might
also inﬂuence adhesive interactions. At low-dose cytocha-
lasin D, no obvious effect on the shape or number of
microvilli on WEHI 274.1 cells was detected by SEM (Fig.
3). This does not, however, rule out changes in mechanical
properties that might be apparent only in the presence of
shear stress. These would not be detected in our system,
since microvilli tethers are too small to be reliably visualized
using our ﬂow chamber. If the compliance of microvilli were
increased by cytochalasin D, this could affect rolling
adhesion. This would not be expected to have a large effect
on b2-integrin–mediated adhesion, since b2-integrins are
localized between microvilli, not at their tips (Erlandsen
et al., 1993; Abitorabi et al., 1997). There could be an effect,
however, on selectin-mediated rolling. Both L-selectin and
PSGL-1 (the major ligand for P-selectin) are localized to
microvillus tips (Picker et al., 1991; Moore et al., 1995). Any
positive effect on PSGL-1–mediated adhesion would have to
involve cooperation with other receptors, though, since
cytochalasin D did not increase adhesion to puriﬁed
P-selectin substrates (Fig. 8).
A key to our ability to detect the role of b2-integrin
diffusion in activation of adhesion under ﬂow was the use of
endothelium from ICAM-1–deﬁcient mice. Endothelial
monolayers have distinct advantages over puriﬁed substrates
for understanding adhesion under ﬂow. Although studies
using puriﬁed substrates have been valuable in advancing
understanding of the properties of individual receptors, they
cannot truly mimic physiologic cell-cell adhesion, because,
in vivo, cell adhesion involves the simultaneous interaction
of multiple sets of adhesion molecules. Use of ICAM-1–
deﬁcient, gene-targeted mouse endothelial cells enabled us
to detect previously unsuspected effects of b2-integrin
diffusion, such as enhancement of capture and rolling. This
also allowed us to avoid the use of blocking antibodies,
which can themselves have effects on cell activation,
confounding interpretation of results.
High temporal and spatial resolution imaging (Kevil et al.,
2003) made possible a detailed analysis of rolling motion
to accurately quantify rolling adhesion and durations. Of
course, at high enough temporal resolution, even smooth
rolling motion consists of a series of discrete steps (Smith
et al., 1999; Chen and Springer, 1999). However, by using
strict criteria for rolling motion (see Materials and Methods)
and quantifying motion 30 times per second, it was possible
to measure velocities only during rolling motion, excluding
periods when the leukocytes either arrested or released from
the endothelium. Quantifying motion in this way gives a truer
measure of rolling velocity than lower sampling frequen-
cies, in which nonrolling behavior is often included in the
average. Thus, it could be determined, for example, that
cytochalasin D increased duration of rolling with no sig-
niﬁcant effect on rolling velocity.
The ICAM-1–dependent effect of cytochalasin D on
rolling (as opposed to ﬁrm adhesion) is particularly in-
teresting. Theb2-integrins are classically associated with ﬁrm
adhesion and cell motility, and, in some systems,b2-integrins
do not mediate tethering or rolling in shear ﬂow (Lawrence
and Springer, 1991; Von Andrian et al., 1991). It is becoming
increasingly clear, however, that the b2-integrin–ICAM-1
interaction can contribute to rolling adhesion. An isolated aL
I-domain linked to a glycophosphatidylinositol GPI anchor
and expressed in baby hamster kidney cells mediated rolling
better than ﬁrm adhesion, demonstrating that, under the right
conditions, the integrin binding site has rolling-receptor
properties (Knorr and Dustin, 1997). Similarly, when LFA-1
was transfected into K562 cells, it mediated rolling better than
ﬁrm adhesion on puriﬁed ICAM-1 (Sigal et al., 2000). In the
same study, however, the Jurkat T-cell line, in which
regulation of b2-integrins is more like that of primary cells,
mediated ﬁrm adhesion rather than rolling under the same
conditions.
Structural studies of the LFA-1 molecule demonstrating
multiple afﬁnity states provide clues as to how the LFA-1–
ICAM-1 interaction mediates both rolling and ﬁrm adhesion,
and how the form of adhesion can depend on the activation
state of the cell. On a leukocyte surface, b2-integrins are
thought to be present in multiple afﬁnity states, the ratio of
which can change with activation (Lollo et al., 1993). Salas
et al., using isolated I-domains mutationally locked in either
the high-afﬁnity (‘‘open’’) or low-afﬁnity (‘‘closed’’) con-
formations, demonstrated that the open conformation medi-
ates ﬁrm adhesion, whereas the closed conformationmediates
rolling (Salas et al., 2002). They also showed that, when
expressed in K562 cells, the wild-typeaLb2 wasmostly in the
closed conformation, and these cells rolled. This makes sense
in terms of the binding kinetics of these constructs. Rapid
kinetics for both association and dissociation are an essential
feature of rolling adhesion (Alon et al., 1995). The engineered
disulﬁde bond that stabilizes the open conformation increases
the on-rate 50-fold and decreases the off-rate 200-fold. The
faster dissociation rate of the low-afﬁnity form would be
predicted to favor rolling adhesion, as was observed.
Recently, an intermediate afﬁnity state for aLb2 has been
deﬁned (Shimaoka et al., 2003). The intermediate confor-
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mation has a relatively fast on-rate as well as a fast off-rate,
and it proves to be more effective as a rolling receptor than
the low-afﬁnity form. It is likely, then, that rolling in-
teractions of b2-integrins with ICAM-1 are mediated by low
and/or intermediate conformations of the integrins.
This raises the question of whether release of integrins
from cytoskeletal constraints affects afﬁnity. The available
evidence argues against this. A change in b2-integrin afﬁnity
in response to cytochalasin D has not been demonstrated.
Indeed, comparison of LFA-1 afﬁnity states among K562
systems that rolled and those that adhered ﬁrmly indicated
that the ability to roll depended on integrin arrangement,
with no change in afﬁnity state (Sigal et al., 2000). However,
afﬁnity measurements in that study and many others gen-
erally depend on binding of soluble ligand. This might not
distinguish the intermediate from the low-afﬁnity state, since
both bind soluble ligand poorly. Therefore, it is possible that,
in addition to increasing integrin diffusion, release from
cytoskeletal constraints also converts integrins from low to
intermediate afﬁnity, which would also promote rolling.
Given the well-known effects of cytochalasin D on b2-
integrin diffusion, though, and the lack of evidence that
release from cytoskeletal constraints affects afﬁnity, we feel
that integrin rearrangement is the simplest interpretation of
the effect of cytochalasin D on WEHI 274.1 cell adhesion.
Cytochalasin D affected not only frequency of rolling
and ﬁrm adhesion, but also their duration. Adhesion of
leukocytes to endothelium is not irreversible. Many cells that
arrest on endothelium do so brieﬂy, resuming rolling after
a few seconds. Similarly, rolling cells often release from the
endothelium after a short time to be carried away by the ﬂow.
Although cytochalasin D increased both duration of rolling
and duration of ﬁrm adhesion, the dose-dependence differed.
The increase in ﬁrm adhesion duration peaked at 0.3 mg/ml,
but increased rolling duration was sustained even at
a concentration of cytochalasin D (3 mg/ml) high enough
to disrupt cytoskeletal architecture (as seen in Fig. 3). The
classic interpretation for the biphasic effect of cytochalasin D
is that, whereas low concentrations are pro-adhesive due
to their effects on integrin rearrangement, doses high enough
to substantially disrupt the cytoskeleton interfere with the
ability of actin to reinforce and stabilize nascent contacts
(Kucik et al., 1996). Our data suggest that cytoskeletal
reinforcement is less important for maintenance of rolling
than for arrest.
Clearly, ICAM-1 plays an important role in adhesion
between monocytes and endothelium, because far fewer cells
per minute rolled and arrested on endothelium lacking
ICAM-1. Not all effects of cytochalasin D could be
explained by the b2-integrin–ICAM-1 interaction, however.
The low level of adhesion on ICAM-1 / endothelium
could still be slightly increased by pretreatment of the
leukocytes with cytochalasin D (as seen in Fig. 1 b). One
possible explanation for this is that, in the absence of ICAM-
1, the b2-integrins bind to other ligands. Mathematical
modeling (Bell, 1978) predicts that increased diffusion of b2-
integrins will increase avidity for any ligand, not just ICAM-
1. Although ICAM-1 is the major b2-integrin ligand found
on endothelial cells, ICAM-2, another aLb2 ligand, is also
present (Issekutz et al., 1999). In addition, aMb2 is known to
have a number of poorly characterized ligands that may
be present on activated endothelial cells (Davis, 1992).
Interactions between b2-integrins and any of these other
ligands could account for the small amount of ICAM-
1–independent adhesive effects.
Alternatively, effects of cytochalasin D on other adhesion
molecules might also result in ICAM-1–independent in-
creased adhesion. Although, so far, increased adhesiveness
in response to cytochalasin D has been described only for
b2-integrins, we tested for effects of cytochalasin D on other
adhesion molecules that might be involved in activation of
leukocyte adhesion. We ﬁrst tested a4b1 because, as with
the b2-integrins, leukocyte adhesion to VCAM-1 via a4b1 is
activatable. In addition, a4b1 associates with the cytoskel-
eton in a regulated manner, clustering and binding to the
cytoskeleton at sites of cell-cell contact (Sanchez-Mateos
et al., 1993). To determine whether cytochalasin D affected
a4b1 avidity, we perfused cells over a puriﬁed VCAM-1
substrate, speciﬁc for a4b1-mediated adhesion. We found
no increase in a4b1-mediated rolling or arrest under ﬂow in
response to cytochalasin D treatment (Fig. 7 a). Since there
was very little ﬁrm adhesion under these conditions, we also
measured adhesion in a brief static assay in the same ﬂow
chamber to conﬁrm that the substrate could mediate
adhesion and that a4b1 was indeed activatable on our cells.
Cells were allowed to settle for 1 min, and then nonadherent
cells were washed away by exposure to high ﬂow rates.
Although PMA activated adhesion fourfold under these
conditions, cytochalasin D had no signiﬁcant effect (Fig. 7
b). This lack of effect of cytochalasin D on a4b1 function is
evidence that a4b1 is not responsible for the ICAM-1–
independent increase in ﬁrm adhesion observed on ICAM-1
/ endothelium. This is consistent with earlier studies in
which a4b1 was transfected into Chinese hamster ovary
(CHO) cells (Yauch et al., 1997). In those cells, a4b1-
mediated adhesion could be activated by PMA, but not by
low-dose cytochalasin D. Direct measurement of a4b1
diffusion in that system demonstrated that cytochalasin D
did not affect a4b1 lateral mobility.
Leukocytes have a number of ligands for endothelial
selectins. If cytochalasin D were to increase diffusion of
any or all of these ligands, it might activate adhesion. We
reasoned that P-selectin–mediated adhesion might be
affected by cytochalasin D, because the major ligand for P
selectin, PSGL-1 (Sako et al., 1993; Moore et al., 1995;
Snapp et al., 1998), is linked to the actin cytoskeleton in
leukocytes via moesin (Snapp et al., 2002), and, thus, might
undergo regulation of diffusion similar to the b2-integrins.
However, low-dose cytochalasin D had no signiﬁcant effect
on adhesion to puriﬁed P-selectin in our system (Fig. 8 a).
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A number of cell-surface molecules serve as ligands for
E-selectin, including PSGL-1 (Sako et al., 1993), and ESL-1
(Steegmaier et al., 1995). (Although L-selectin binds directly
to E-selectin in humans, it is not a ligand in mice (Zollner
et al., 1997)). Other E-selectin ligands may exist, since no
combination of antibodies has yet been demonstrated to
completely block E-selectin binding (Kansas, 2001). There-
fore, it is difﬁcult to account for all of the possible E-selectin
ligands on a given leukocyte. Even without identifying the
speciﬁc ligands present, however, the global effect of cyto-
chalasin D on all E-selectin ligands can be tested func-
tionally by measuring the dose dependence of cytochalasin D
on WEHI cell rolling on a puriﬁed E-selectin substrate. We
found that the low doses that activate integrin-mediated
adhesion had no signiﬁcant effect on ﬁrm adhesion to E-
selectin (Fig. 9 b), and actually decreased rolling interactions
(Fig. 8 b).
One of the most interesting ﬁndings was the requirement
for cooperativity among adhesion receptors for avidity
effects under ﬂow (Fig. 9). On puriﬁed ICAM-1 alone, there
was very little ﬁrm adhesion at a shear stress of 2.5 dynes/
cm2 (perhaps due to the inefﬁciency of tethering), and
adhesion was not increased by cytochalasin D. Tethering
was more efﬁcient on E-selectin alone, and this resulted in
some ﬁrm adhesion, but cytochalasin D had no effect. On
a substrate of combined puriﬁed ICAM-1 and E-selectin,
however, the pro-adhesive effect of cytochalasin D could be
reconstituted. This conﬁrms the role of ICAM-1 (and its
receptors, the b2-integrins) in the adhesive effects of
cytochalasin D, but shows that cooperativity with another
receptor is required. A simple interpretation would be that,
for cytochalasin D to increase b2-integrin adhesion to
ICAM-1, cells must ﬁrst be in contact with the endothelium,
and this requires an additional receptor to mediate capture
and rolling. This is consistent with previous work that
suggested that E-selectin and ICAM-1 work together for
optimal leukocyte adhesion. In that study, L-cells transfected
with both E-selectin and ICAM-1 could support far greater
adhesion, both rolling and ﬁrm, than those expressing either
receptor alone (Gopalan et al., 1997).
The requirement for cooperativity between integrins and
selectins may result either from physical cooperation
between receptors or from receptor-mediated signaling. It
has been demonstrated that efﬁciency of ﬁrm adhesion
through b2-integrins decreases as shear increases, suggesting
a requirement for a collisional contact duration of at least
5 ms (Lynam et al., 1998; Neelamegham et al., 1998). Thus,
interactions between E-selectin and its ligands may slow the
cell and provide for increased contact duration.
E-selectin does more, however, than simply tethering the
leukocyte to increase the contact time. E-selectin binding by
neutrophils can activate b2-integrin–mediated adhesion
through mitogen-activated protein kinases (Simon et al.,
2000). In this study, on a combined substrate of ICAM-1 and
E-selectin, adhesion could be increased by cytochalasin D.
This suggests that signaling through E-selectin binding is not
sufﬁcient to fully activate integrin-mediated adhesion. A
possible explanation is that integrin rearrangement can
work synergistically with effects on afﬁnity, with the two
regulated independently. For example, signaling through E-
selectin might increase b2-integrin afﬁnity, yet independent
control of rearrangement might allow for further avidity
increases. Future studies will be aimed at further elucidating
the biochemical basis of these effects.
In summary, using low-dose cytochalasin D to mimic the
increased integrin diffusion that occurs upon leukocyte
activation, we have demonstrated that avidity modulation
can have major effects on leukocyte adhesion to endothelium
under ﬂow. Effects involve not only ﬁrm adhesion, a well-
established b2-integrin function, but also capture and rolling,
in which b2-integrins and ICAM-1 must cooperate with
selectins to exert their effects. These functional assays pro-
vide a proof of principle for regulation of leukocyte adhesion
under ﬂow by avidity regulation, and lay the groundwork for
investigation of the molecular mechanisms by which integrin
diffusion is controlled during adhesion in the presence of
shear. Our ﬁndings not only have important implications for
the mechanism of activation of adhesion, but reveal that
cooperativity among sets of adhesion molecules plays
a larger role than expected.
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